Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Surg Oncol Clin N Am. 2010 Jan;19(1):101–113. doi: 10.1016/j.soc.2009.09.004

Figure 2.

Figure 2

Recurrence-free survival. Reprinted with permission from Ronald P DeMatteo, Karla V Ballman, Cristina R Antonescu et al, Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial, The Lancet, Volume 373, Issue 9669, 28 March 2009-3 April 2009, Pages 1097–1104,